Proprotein convertase subtilisin/kexin type 9 (PCSK9): From structure-function relation to therapeutic inhibition

QR Code

Proprotein convertase subtilisin/kexin type 9 (PCSK9): From structure-function relation to therapeutic inhibition

Aims: This short review aims at summarizing the current information on Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) structure and function focusing also on the therapeutic possibilities based on the inhibition of this protein. Data synthesis: PCSK9 has been recently discovered as the third...

Full description

Bibliographic Details
Main Authors:	Tibolla, G., Norata, Giuseppe, Artali, R., Meneghetti, F., Catapano, A.
Format:	Journal Article
Published:	Elsevier 2011
Online Access:	http://hdl.handle.net/20.500.11937/55419

Similar Items

Proprotein Convertase Subtilisin-Kexin type-9 (PCSK9) and triglyceride-rich lipoprotein metabolism: Facts and gaps
by: Baragetti, A., et al.
Published: (2018)

Biology of proprotein convertase subtilisin kexin 9: Beyond low-density lipoprotein cholesterol lowering
by: Norata, Giuseppe, et al.
Published: (2016)

PCSK9 inhibition for the treatment of hypercholesterolemia: Promises and emerging challenges
by: Norata, Giuseppe, et al.
Published: (2014)

Targeting PCSK9 for hypercholesterolemia
by: Norata, Giuseppe, et al.
Published: (2014)

PCSK9 inhibition in statin-intolerant HeFH patients: What's new?
by: Casula, M., et al.
Published: (2017)

PCSK9 inhibitors and dyslipidemia: The clinical evidence
by: Norata, Giuseppe
Published: (2014)

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: Patient selection and perspectives
by: Catapano, A., et al.
Published: (2017)

PCSK9 deficiency results in increased ectopic fat accumulation in experimental models and in humans
by: Baragetti, A., et al.
Published: (2017)

Squaring up the health economics of PCSK9 monoclonal antibodies ‘down under’
by: Watts, G., et al.
Published: (2018)

In vivo and in vitro effects of phaleria macrocarpa (scheff.) boerl on low density lipoprotein and pcsk9 expression
by: Chong, Soo Ching
Published: (2011)

Phaleria macrocarpa (Scheff.) Boerl fruit aqueous extract enhances LDL receptor and PCSK9 expression in vivo and in vitro.
by: Chong, Soo Ching, et al.
Published: (2011)

Association Of Single Nucleotide Polymorphisms (Snp) In Pcsk9 Gene With Lipid Analysis Among Iban And Bidayuh Ethnic Groups In Sarawak Population.
by: H. H., Hood, et al.
Published: (2015)

New therapeutic principles in dyslipidaemia: Focus on LDL and Lp(a) lowering drugs
by: Norata, Giuseppe, et al.
Published: (2013)

Versatility of subtilisin: a review on structure, characteristics, and applications
by: Mohd Azrin, Nur Aliyah, et al.
Published: (2022)

PCSK9 inhibitory activity of marine-derived compounds, aaptaminoids, and benzamide originated from Aaptos aaptos and Acanthaster planci as a potential treatment for atherosclerosis.
by: Habsah, Mohamad, et al.
Published: (2020)

New therapeutic principles for familial hypercholesterolemia
by: Norata, Giuseppe
Published: (2014)

Niemann-pick C1-like 1 (NPC1L1) inhibition and cardiovascular diseases
by: Pirillo, A., et al.
Published: (2016)

Gene silencing approaches for the management of dyslipidaemia
by: Norata, Giuseppe, et al.
Published: (2013)

Statins and skeletal muscles toxicity: From clinical trials to everyday practice
by: Norata, Giuseppe, et al.
Published: (2014)

c-Met inhibition in aHOXA9/Meis1model of CN-AML
by: Mulgrew, Nuala M., et al.
Published: (2013)

Potential utilization of phenolic acid compounds as anti-inflammatory agents through TNF-α Convertase inhibition mechanisms: a network pharmacology, docking, and molecular dynamics approach
by: Ekowati, Juni, et al.

Mutagenic study of benzimidazole derivatives with (+S9) and without (−S9) metabolic activation
by: Azahar, Nurul Hafizan, et al.
Published: (2019)

9-Benzyl-6-benzylsulfanyl-9H-purin-2-amine
by: Hariono, Maywan, et al.
Published: (2014)

The myth of 9/11
by: Formby, Zoë
Published: (2011)

Bab 9: Ingatan
by: Yahaya, Azizi, et al.
Published: (2005)

Bab 9: Ingatan
by: Yahaya, Azizi, et al.
Published: (2005)

HDL: To treat or not to treat?
by: Pirillo, A., et al.
Published: (2014)

Host defence peptide (HDP) human beta defensin 9 (HBD9)
by: Omar, Nazri
Published: (2016)

In silico sequence analysis, homology modeling and function annotation of putative subtilisin-like serine protease from Cryptosporidium parvum
by: Mat Yusof, Afzan, et al.
Published: (2018)

9 Sekeluarga bergraduasi serentak
by: UMP, PNC
Published: (2019)

E-Citra Artwork9
by: Halim, H.
Published: (2014)

Semua 9A+ layak
by: Berita harian, Nazura Ngah
Published: (2010)

Pengumuman dari Chanel 9
by: Universiti Putra Malaysia, Bahagian Komunikasi Korporat
Published: (2010)

9,010 receive scholarships
by: Kannan, Hashini Kavishtri
Published: (2016)

Bab 9 : Pemikiran kritikal
by: Hashim, Shahrin
Published: (2010)

Leonurine: A new comer in the natural compounds affecting atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2012)

Statins and periodontal inflammation: A pleiotropic effect of statins or a pleiotropic effect of LDL-cholesterol lowering?
by: Norata, Giuseppe, et al.
Published: (2014)

HDL and adaptive immunity: A tale of lipid rafts
by: Norata, Giuseppe, et al.
Published: (2012)

Therapeutic concentrations of antidepressants inhibit pancreatic beta-cell function via mitochondrial complex inhibition
by: Elmorsy, Ekramy, et al.
Published: (2017)

Aug 9, 2012 bronze, Aug 9, 2016 silver Aug, 17 2016 gold?
by: The Star,
Published: (2016)